Ad35.RSV.FA2
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ad35.RSV.FA2, covering 2016-11-01 to 2017-08-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad35.RSV.FA2 Regimens Boosted With Ad26.RSV.FA2 in Healthy Adult Participants [Phase 1]